Friday, June 20, 2025 | 05:17 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

With few other options, clinicians back plasma though efficacy not proven

Experts feel that ICMR guidelines may not be binding upon hospitals unless DCGI gives a direction against use of the investigational therapy

doctors, patients, medical, health, hospitals, coronavirus, plasma, covid, blood
premium

Experts feel that ICMR guidelines may not be binding upon hospitals

Ruchika ChitravanshiSohini Das New Delhi/Mumbai
With the Indian Council of Medical Research (ICMR) likely to delete convalescent plasma therapy from its national guidelines for Covid-19 treatment, medical experts are batting in its favour given that there is no definitive remedy available against the virus till now and some patients have benefitted from the plasma. 

According to a senior government doctor with the Delhi government, “If there was any targeted therapy working for covid then it was okay to shut down plasma banks. Plasma therapy might not be showing any benefits but it is also not showing any negative effects in the patients. It has in fact,